MANGOCEUTICALS, INC. 8K

Mangoceuticals, Inc. and Nuclea Energy Inc. mutually terminated their July 29, 2026 business combination agreement on August 19, 2026 after failing to secure the required $15 million PIPE financing by the outside closing date.

Mangoceuticals, Inc. and Nuclea Energy Inc., together with the principal shareholders and principals party to their July 29, 2026 Business Combination Agreement, mutually agreed on August 19, 2026 to terminate the agreement after determining that a key closing condition—completion of a PIPE financing of at least $15 million with funds deposited into escrow by the August 21, 2026 outside date—could not be satisfied, rendering the transaction unable to close on the contemplated terms; the termination is effected under the BCA’s mutual consent provision, leaves certain confidentiality and general provisions in force, allocates each party its own costs, preserves liability for any prior willful breaches, and includes mutual releases of claims related to the BCA and its ancillary documents through the termination date.

Filing Facts

CIK

1938046

Ticker

-

Form

8K

Source Type

sec

Accession

0001493152-26-039724

Alert Tier

8